191A — MIMOSA Co Income Statement
0.000.00%
HealthcareHighly SpeculativeMicro Cap
Annual income statement for MIMOSA Co, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | Tanshin | Tanshin |
Standards: | JAS | JAS | — | — |
Status: | Final | Final | Final | Final |
Revenue | ||||
Total Revenue | 12,761 | 13,928 | 14,966 | 16,344 |
Cost of Revenue | ||||
Gross Profit | 1,322 | 1,270 | 1,571 | 1,374 |
Selling / General / Administrative Expenses | ||||
Depreciation and Amortization | ||||
Unusual Expense / Income | ||||
Other Operating Expenses | ||||
Total Operating Expenses | 12,593 | 13,878 | 14,814 | 16,379 |
Operating Profit | 168 | 50.3 | 152 | -35.3 |
Total Net Non Operating Interest Income / Expense | ||||
Other Net Non Operating Costs | ||||
Net Income Before Taxes | 219 | 221 | 384 | 97.8 |
Provision for Income Taxes | ||||
Net Income After Taxes | 175 | 152 | 262 | 53.3 |
Net Income Before Extraordinary Items | ||||
Net Income | 175 | 152 | 262 | 53.3 |
Adjustments to Net Income | ||||
Income Available to Common Shareholders Excluding Extraordinary Items | ||||
Income Available to Common Shareholders Including Extraordinary Items | ||||
Diluted Net Income | 175 | 152 | 262 | 53.3 |
Diluted Weighted Average Shares | ||||
Basic EPS Including Extraordinary Items | ||||
Diluted EPS Including Extraordinary Items | ||||
Diluted EPS Excluding Extraordinary Items | ||||
Normalised Income Before Taxes | ||||
Normalised Income After Taxes | ||||
Normalised Income Available to Common Shareholders | ||||
Diluted Normalised EPS | 266 | 227 | 386 | 82.3 |
Dividends per Share |